Jonathan Braverman

The Braverman lab is focused on developing precision organoid models across a number of health applications including cancer, infectious disease, and rare/neglected diseases.

Research directions include studying the tissue-level biology of colon cancer with the aim of identifying synthetic vulnerabilities, developing organoid co-culture models to facilitate development of next generation immunotherapies, and leveraging CRISPRa/i tools to study host/pathogen interactions and therapeutically modulate immune responses.